DNDana E. Nedelcu
Dana E. Nedelcu
*This is an algorithmically generated author record based on publicly available information.
Research Subjects
Dana E. Nedelcu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adrian-Iustin Georgevici
Department of Anesthesiology, St. Josef Hospital of Ruhr-University of Bochum, 44791 Bochum, Germany
1 shared publication - Christiana Diana Maria Dragosloveanu
Department of Ophthalmology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication - Cristian Valentin Toma
Department of Urology, University of Medicine and Pharmacy “Carol Davila”, 020021 Bucharest, Romania
1 shared publication - Eduard Lucian Catrina
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication - Iulian Brezean
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication - Lidia Ladea
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania
1 shared publication
Latest Publications
- Open Access
- 27 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8411
Risk Factors Associated with Corneal Nerve Fiber Length Reduction in Patients with Type 2 Diabetes
Background: Diabetic neuropathy affects almost half of diabetic patients, yet the relative contributions of metabolic, vascular and clinical factors remain controversial. We aimed to investigate which risk factors are more associated with reduced corneal nerve fiber length (CNFL). Methods: This is a cross-sectional study of 30 patients with type 2 diabetes. We assessed metabolic parameters (HbA1c, lipids), vascular measurements (Doppler ultrasonography of carotid and ophthalmic arteries, central vessel density measured by optical coherence tomography angiography), and corneal epithelial thickness. We explored the data using network analysis, then applied penalized mixed-effect regression (in which represents the standardized coefficients with mean 0 and unit standard deviation), followed by generalized additive models and polynomial transformations. Results: Penalized regression identified vascular parameters as dominant predictors: carotid plaques ( = −0.609) and intima-media thickness ( = −0.574) showed the strongest associations with CNFL. Traditional metabolic markers including HbA1c failed to meet selection thresholds. Bifurcation velocity ( = −0.313) and corneal sensitivity measures ( = 0.278–0.135) were also significant. The non-linear modeling showed complex vascular–structural interactions. Conclusions: Vascular compromise, particularly carotid disease, had the highest association with CNFL in our cohort. Thus, our study reports a higher effect of vascular parameters than HbA1c in patients with a longer history of diabetes. This may reflect the progression of diabetic complications, where initial metabolic insults are followed by vascular pathology as the primary driver of end-organ damage. Our findings highlight the need for carotid artery screening in diabetic patients for a better estimation of the neuropathy risk.- 27 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (23) , 8411
Open AccessRisk Factors Associated with Corneal Nerve Fiber Length Reduction in Patients with Type 2 Diabetes
Background: Diabetic neuropathy affects almost half of diabetic patients, yet the relative contributions of metabolic, vascular and clinical factors remain controversial. We aimed to investigate which risk factors are more associated with reduced corneal nerve fiber length (CNFL). Methods: This is a cross-sectional study of 30 patients with type 2 diabetes. We assessed metabolic parameters (HbA1c, lipids), vascular measurements (Doppler ultrasonography of carotid and ophthalmic arteries, central vessel density measured by optical coherence tomography angiography), and corneal epithelial thickness. We explored the data using network analysis, then applied penalized mixed-effect regression (in which represents the standardized coefficients with mean 0 and unit standard deviation), followed by generalized additive models and polynomial transformations. Results: Penalized regression identified vascular parameters as dominant predictors: carotid plaques ( = −0.609) and intima-media thickness ( = −0.574) showed the strongest associations with CNFL. Traditional metabolic markers including HbA1c failed to meet selection thresholds. Bifurcation velocity ( = −0.313) and corneal sensitivity measures ( = 0.278–0.135) were also significant. The non-linear modeling showed complex vascular–structural interactions. Conclusions: Vascular compromise, particularly carotid disease, had the highest association with CNFL in our cohort. Thus, our study reports a higher effect of vascular parameters than HbA1c in patients with a longer history of diabetes. This may reflect the progression of diabetic complications, where initial metabolic insults are followed by vascular pathology as the primary driver of end-organ damage. Our findings highlight the need for carotid artery screening in diabetic patients for a better estimation of the neuropathy risk.